%0 Journal Article
%T Hipercalcemia como efecto secundario de los quelantes de potasio
%A Arroyo
%A David
%A Panizo
%A Nayara
%A Garc¨ªa de Vinuesa
%A Soledad
%A Goicoechea
%A Marian
%A Verdalles
%A ¨²rsula
%A Lu£¿o
%A Jos¨¦
%J Nefrolog¨ªa (Madrid)
%D 2012
%I Scientific Electronic Library Online
%R 10.3265/Nefrologia.pre2012.Jun.11500
%X hypercalcaemia is a potential adverse effect of calcium-containing ion exchange resins, often used in the treatment and prevention of hyperkalaemia in chronic kidney disease (ckd). we describe a series of seven outpatients with moderate ckd (mean glomerular filtration rate estimated with the ckd-epi formula: 41.29¡À10.83ml/min/1.73m2), presenting mild hypercalcaemia in relation to the treatment with calcium polystyrene sulfonate. serum calcium increased a mean of 0.91¡À0.46mg/dl, with a mean concomitant decrease of serum intact parathormone (ipth) of 52.24¡À49.29ng/dl. after treatment withdrawal or dose reduction, we observed a recovery of serum calcium and ipth values. treatment with calcium-based potassium binders should be included in the differential diagnosis of hypercalcaemia in patients with moderate ckd.
%K ion exchange resins
%K hypercalcaemia
%K hyperpotassemia
%K polystyrene sulfonate calcium.
%U http://scielo.isciii.es/scielo.php?script=sci_abstract&pid=S0211-69952012000700013&lng=en&nrm=iso&tlng=en